PF-AtlasClinical Trials › NCT07245407

A Translational Study for Phenotyping and Endotyping Chinese Patients With NCFBE

Participant Follow-up · Not specified

Registry ID
NCT07245407
Phase
Not specified
Status
Recruiting
Drug / intervention
Participant Follow-up
Sponsor
AstraZeneca
Start
2025-10-27
Enrollment
320
Locations
38

About this trial

Non-cystic fibrosis bronchiectasis (NCFBE) is a chronic respiratory disease characterized by a clinical syndrome of chronic productive cough and recurrent respiratory infections in the presence of abnormal and permanent dilation of the bronchi. Recent epidemiological studies have clearly shown that the prevalence and incidence of NCFBE are quickly rising both in high- and low-income countries. With the increase of prevalence, bronchiectasis brings huge medical and economic burden to the society. In this study, the investigator will perform biomarker assessments and multi-omics analysis on NCFBE patients and healthy participants in China to validate the link of disease pathways to pathophysiological features and uncover the molecular endotypes behind clinical phenotypesof Chinese patients with NCFBE.

View NCT07245407 on ClinicalTrials.gov →

Explore related

Medical disclaimer. This page summarizes public trial data for NCT07245407 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.